IA
IMVT icon

IFP Advisors’s Immunovant IMVT Stock Holding History

IFP Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149 Hold
6
– – ﹤0.01% 4669
2025
Q4 		$153 Hold
6
– – ﹤0.01% 4519
2025
Q3 		$97 Buy
+6
New +$97 ﹤0.01% 4546
2025
Q2 		– Hold
0
– – – 3402
2025
Q1 		– Hold
0
– – – 3775
2024
Q4 		– Hold
0
– – – 3755
2022
Q4 		– Sell
-10
Closed -$1K – 4709
2022
Q3 		$1K Hold
10
– – ﹤0.01% 4584
2022
Q2 		$1K Hold
10
– – ﹤0.01% 4357
2022
Q1 		$1K Buy
+10
New +$62 ﹤0.01% 4356

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

IFP Advisors's IMVT Position: Q1 2026 in Review

IFP Advisors held its Immunovant (IMVT) position steady in Q1 2026 at 6 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #4669.

IFP Advisors first reported a position in IMVT in Q1 2022 and has held it in 6 quarters since. The position peaked at $1K in Q3 2022. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • IFP Advisors held 6 shares of Immunovant worth $149 as of Q1 2026.
  • IFP Advisors left its Immunovant share count unchanged in Q1 2026.
  • Immunovant made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4669 holding.
  • IFP Advisors first reported a position in Immunovant in Q1 2022 and has held it in 6 quarters since.
  • IFP Advisors's Immunovant position peaked at $1K in Q3 2022.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.